Welcome
Health Law & Business News

Takeda Sues Mylan Over License Agreement on Copycat Colcrys Drug

Dec. 2, 2019, 11:14 PM

Takeda filed a lawsuit accusing Mylan of breaching a license agreement stemming from the settlement of a patent-infringement case over Colcrys, drug used to treat gout flare-ups.

  • Takeda also is suing for patent infringement, with the dispute centering on Mylan’s launch of generic colchicine, Colcrys’s active ingredient, before it had permission to do so, according to Mylan’s expedited request for confidential treatment, filed Monday in federal court in Wilmington, Delaware
    • Takeda also filed sealed complaint, filing says
  • Takeda and Mylan reached confidential settlement and license agreements in December 2017 in another Delaware case; the agreements also ended a related patent-infringement...





To read the full article log in. To learn more about a subscription click here.